Fresenius Operating Income from 2010 to 2025

FMS Stock

USD 24.21 0.41 1.72%

Fresenius Medical Operating Income yearly trend continues to be comparatively stable with very little volatility. Operating Income will likely drop to about 1.4 B in 2025. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Fresenius Medical Care generates from its operations. View All Fundamentals

Operating Income

First Reported

1997-03-31

Previous Quarter

462.7 M

Current Value

437.4 M

Quarterly Volatility

387.1 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Fresenius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fresenius Medical's main balance sheet or income statement drivers, such as Interest Expense of 246 M, Total Revenue of 11.7 B or Gross Profit of 3.8 B, as well as many indicators such as Price To Sales Ratio of 0.63, Dividend Yield of 0.0286 or PTB Ratio of 0.84. Fresenius financial statements analysis is a perfect complement when working with Fresenius Medical Valuation or Volatility modules.

Check out the analysis of Fresenius Medical Correlation against competitors.

Latest Fresenius Medical's Operating Income Growth Pattern

Below is the plot of the Operating Income of Fresenius Medical Care over the last few years. Operating Income is the amount of profit realized from Fresenius Medical Care operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Fresenius Medical Care is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Fresenius Medical's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Fresenius Medical's overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

Fresenius Operating Income Regression Statistics

	Arithmetic Mean	1,572,768,907
	Coefficient Of Variation	58.97
	Mean Deviation	701,228,484
	Median	1,633,892,019
	Standard Deviation	927,396,248
	Sample Variance	860063.8T
	Range	3.3B
	R-Value	(0.53)
	Mean Square Error	658226.3T
	R-Squared	0.29
	Significance	0.03
	Slope	(104,117,986)
	Total Sum of Squares	12900957T

Fresenius Operating Income History

	2025	1.4 B
	2024	1.4 B
	2023	1.4 B
	2022	-258.4 M
	2021	301.3 M
	2020	529 M
	2019	710 M

Other Fundumenentals of Fresenius Medical Care

Non Operating Income Net Other

Fresenius Medical Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Current Deferred Revenue	Long Term Debt	Property Plant Equipment	Good Will	Short Term Investments	Net Tangible Assets	Long Term Investments	Short Long Term Debt	Treasury Stock	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Cash And Equivalents	Net Working Capital	Capital Stock
Total Assets		0.98	0.93	0.87	0.95	0.85	0.99	0.96	0.72	-0.33	0.5	-0.03	0.43	0.77	0.91	0.59	0.04	0.45	-0.72	0.34	0.66	-0.67	0.18	0.05	0.25	-0.22
Total Stockholder Equity	0.98		0.86	0.87	0.96	0.87	0.95	0.97	0.74	-0.36	0.52	-0.06	0.35	0.72	0.91	0.58	0.13	0.43	-0.73	0.45	0.58	-0.64	0.21	0.19	0.3	-0.22
Net Debt	0.93	0.86		0.77	0.82	0.74	0.97	0.83	0.67	-0.24	0.39	0.01	0.5	0.77	0.81	0.52	-0.1	0.36	-0.6	0.09	0.75	-0.65	0.13	-0.2	0.05	-0.18
Retained Earnings	0.87	0.87	0.77		0.86	0.76	0.85	0.86	0.61	-0.35	0.49	-0.07	0.34	0.9	0.97	0.66	-0.01	0.53	-0.82	0.33	0.64	-0.84	0.26	0.12	0.36	-0.61
Accounts Payable	0.95	0.96	0.82	0.86		0.94	0.91	0.96	0.63	-0.43	0.62	0.12	0.47	0.66	0.92	0.67	0.01	0.44	-0.75	0.5	0.51	-0.57	0.23	0.11	0.28	-0.21
Net Receivables	0.85	0.87	0.74	0.76	0.94		0.83	0.91	0.58	-0.47	0.64	0.32	0.59	0.48	0.85	0.63	-0.1	0.28	-0.75	0.57	0.28	-0.36	0.15	0.12	0.12	-0.05
Total Liab	0.99	0.95	0.97	0.85	0.91	0.83		0.93	0.71	-0.32	0.48	0.02	0.47	0.77	0.89	0.58	-0.02	0.39	-0.7	0.28	0.68	-0.67	0.13	-0.03	0.16	-0.2
Total Current Assets	0.96	0.97	0.83	0.86	0.96	0.91	0.93		0.68	-0.36	0.52	0.03	0.46	0.65	0.9	0.58	0.09	0.43	-0.73	0.49	0.49	-0.56	0.18	0.23	0.34	-0.16
Short Term Debt	0.72	0.74	0.67	0.61	0.63	0.58	0.71	0.68		-0.02	0.12	-0.33	-0.02	0.55	0.61	0.17	0.42	-0.02	-0.39	0.48	0.33	-0.5	0.04	0.32	-0.16	-0.04
Intangible Assets	-0.33	-0.36	-0.24	-0.35	-0.43	-0.47	-0.32	-0.36	-0.02		-0.94	-0.55	-0.4	-0.16	-0.42	-0.31	0.08	-0.09	0.45	-0.33	-0.01	0.12	-0.05	-0.14	-0.06	0.03
Common Stock	0.5	0.52	0.39	0.49	0.62	0.64	0.48	0.52	0.12	-0.94		0.59	0.4	0.27	0.57	0.58	-0.22	0.25	-0.64	0.42	0.15	-0.22	0.09	0.08	0.1	-0.08
Current Deferred Revenue	-0.03	-0.06	0.01	-0.07	0.12	0.32	0.02	0.03	-0.33	-0.55	0.59		0.53	-0.31	0.03	0.37	-0.52	-0.19	-0.18	0.18	-0.29	0.31	-0.3	-0.17	-0.3	0.32
Long Term Debt	0.43	0.35	0.5	0.34	0.47	0.59	0.47	0.46	-0.02	-0.4	0.4	0.53		0.21	0.45	0.3	-0.36	0.09	-0.32	-0.11	0.16	-0.03	-0.01	-0.22	0.0	0.05
Property Plant Equipment	0.77	0.72	0.77	0.9	0.66	0.48	0.77	0.65	0.55	-0.16	0.27	-0.31	0.21		0.83	0.52	-0.02	0.58	-0.61	-0.03	0.86	-0.93	0.31	-0.11	0.32	-0.74
Good Will	0.91	0.91	0.81	0.97	0.92	0.85	0.89	0.9	0.61	-0.42	0.57	0.03	0.45	0.83		0.68	-0.09	0.49	-0.85	0.37	0.6	-0.72	0.27	0.06	0.32	-0.49
Short Term Investments	0.59	0.58	0.52	0.66	0.67	0.63	0.58	0.58	0.17	-0.31	0.58	0.37	0.3	0.52	0.68		-0.49	0.6	-0.74	0.19	0.51	-0.46	0.23	-0.08	0.3	-0.41
Net Tangible Assets	0.04	0.13	-0.1	-0.01	0.01	-0.1	-0.02	0.09	0.42	0.08	-0.22	-0.52	-0.36	-0.02	-0.09	-0.49		-0.32	0.28	0.37	-0.16	-0.1	0.0	0.63	0.08	0.14
Long Term Investments	0.45	0.43	0.36	0.53	0.44	0.28	0.39	0.43	-0.02	-0.09	0.25	-0.19	0.09	0.58	0.49	0.6	-0.32		-0.44	-0.17	0.68	-0.5	0.36	-0.17	0.73	-0.58
Short Long Term Debt	-0.72	-0.73	-0.6	-0.82	-0.75	-0.75	-0.7	-0.73	-0.39	0.45	-0.64	-0.18	-0.32	-0.61	-0.85	-0.74	0.28	-0.44		-0.43	-0.39	0.58	-0.22	-0.07	-0.29	0.41
Treasury Stock	0.34	0.45	0.09	0.33	0.5	0.57	0.28	0.49	0.48	-0.33	0.42	0.18	-0.11	-0.03	0.37	0.19	0.37	-0.17	-0.43		-0.33	-0.04	0.01	0.51	0.03	0.19
Long Term Debt Total	0.66	0.58	0.75	0.64	0.51	0.28	0.68	0.49	0.33	-0.01	0.15	-0.29	0.16	0.86	0.6	0.51	-0.16	0.68	-0.39	-0.33		-0.79	0.27	-0.39	0.34	-0.57
Capital Surpluse	-0.67	-0.64	-0.65	-0.84	-0.57	-0.36	-0.67	-0.56	-0.5	0.12	-0.22	0.31	-0.03	-0.93	-0.72	-0.46	-0.1	-0.5	0.58	-0.04	-0.79		-0.12	0.0	-0.31	0.75
Net Invested Capital	0.18	0.21	0.13	0.26	0.23	0.15	0.13	0.18	0.04	-0.05	0.09	-0.3	-0.01	0.31	0.27	0.23	0.0	0.36	-0.22	0.01	0.27	-0.12		-0.1	0.51	-0.31
Cash And Equivalents	0.05	0.19	-0.2	0.12	0.11	0.12	-0.03	0.23	0.32	-0.14	0.08	-0.17	-0.22	-0.11	0.06	-0.08	0.63	-0.17	-0.07	0.51	-0.39	0.0	-0.1		0.15	0.09
Net Working Capital	0.25	0.3	0.05	0.36	0.28	0.12	0.16	0.34	-0.16	-0.06	0.1	-0.3	0.0	0.32	0.32	0.3	0.08	0.73	-0.29	0.03	0.34	-0.31	0.51	0.15		-0.44
Capital Stock	-0.22	-0.22	-0.18	-0.61	-0.21	-0.05	-0.2	-0.16	-0.04	0.03	-0.08	0.32	0.05	-0.74	-0.49	-0.41	0.14	-0.58	0.41	0.19	-0.57	0.75	-0.31	0.09	-0.44

Click cells to compare fundamentals

About Fresenius Medical Financial Statements

Fresenius Medical shareholders use historical fundamental indicators, such as Operating Income, to determine how well the company is positioned to perform in the future. Although Fresenius Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Fresenius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Fresenius Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Operating Income	1.4 B	1.4 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Fresenius Stock Analysis

When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Fresenius Operating Income from 2010 to 2025

Latest Fresenius Medical's Operating Income Growth Pattern

Fresenius Operating Income Regression Statistics

Fresenius Operating Income History

Other Fundumenentals of Fresenius Medical Care

Fresenius Medical Operating Income component correlations

About Fresenius Medical Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Fresenius Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY